Login to Your Account

GHIT injected with $200M in funding

By Kohei Kanayasu
Staff Writer

Wednesday, June 7, 2017

TOKYO – With $200 million in new funding, the Global Health Innovative Technology (GHIT) Fund is poised to continue funding early and midstage drug development projects for the next five years, particularly for neglected diseases that disproportionately affect developing markets.

To continue reading subscribe now to Latest News

Learn More about Latest News

Already a subscriber? Sign In or Buy now to activate your subscription